Page 1 of Clinical Trials for Biological recombinant interferon alpha-2a, 300 Total Matches
- 1CompletedLast Updated: September 27, 2010Condition(s): Leukemia
- 2CompletedLast Updated: November 5, 2011Condition(s): Melanoma (Skin)
- 3WithdrawnLast Updated: May 10, 2011Condition(s): Leukemia; Multiple Myeloma and Plasma Cell Neoplasm
- 4CompletedLast Updated: February 6, 2009Condition(s): Melanoma (Skin)
- 5CompletedLast Updated: February 6, 2009Condition(s): Kidney Cancer
- 6CompletedLast Updated: May 10, 2011Condition(s): Kidney Cancer; Melanoma (Skin); Unspecified Adult Solid Tumor, Protocol Specific
- 7CompletedLast Updated: February 13, 2010Condition(s): Colorectal Cancer; Kidney Cancer
- 8Active, not recruitingLast Updated: June 4, 2011Condition(s): Leukemia
- 9Active, not recruitingLast Updated: July 18, 2011Condition(s): Melanoma (Skin)
- 10Active, not recruitingLast Updated: February 6, 2009Condition(s): Kidney Cancer
- 11Active, not recruitingLast Updated: February 6, 2009Condition(s): Breast Cancer; Chronic Myeloproliferative Disorders; Gestational Trophoblastic Tumor; Kidney Cancer; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Neuroblastoma; Ovarian Cancer; Sarcoma; Testicular Germ Cell Tumor
- 12WithdrawnLast Updated: January 25, 2012Condition(s): Melanoma
- 13Active, not recruitingLast Updated: February 6, 2009Condition(s): Colorectal Cancer
- 14Active, not recruitingLast Updated: October 14, 2011Condition(s): Multiple Myeloma and Plasma Cell Neoplasm
- 15Active, not recruitingLast Updated: February 6, 2009Condition(s): Leukemia
- 16TerminatedLast Updated: May 16, 2011Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- 17Active, not recruitingLast Updated: February 6, 2009Condition(s): Kidney Cancer
- 18RecruitingLast Updated: February 2, 2010Condition(s): Unspecified Adult Solid Tumor, Protocol Specific
- 19Active, not recruitingLast Updated: March 15, 2012Condition(s): Kidney Cancer
- 20Active, not recruitingLast Updated: February 6, 2009Condition(s): Lymphoma
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Biological+recombinant+interferon+alpha-2a
